Mindset Pharma Inc.

Mindset Pharma Inc. is a Canada-based drug discovery and development company focused on creating optimized and patentable psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. The Company is developing various families of psychedelic compounds, as well as a process to chemically synthesize psilocybin in addition to its own proprietary compounds. The Company, through the McQuade Center, covers multiple drug development programs. The Company has developed 4 families of next-generation psychedelics with differentiated characteristics. The Company's portfolio consists of macrodosing and microdosing. Its macrodosing includes Family 1/MSP-1014, Family 2, and Family 4. The MSP-1014 is a new chemical entity that incorporates a conjugated amplifier into a psilocybin-like structure to create an effective drug. The Company's Family 3 is a long-acting next-generation psychedelic drug positioned for micro-dosing.